Frontiers | TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Frontiers | Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients
Biomedicines | Free Full-Text | Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management
Therapeutic strategies to target RAS-mutant cancers | Nature Reviews Clinical Oncology
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma | International Journal of Oral Science
Emerging new therapeutic antibody derivatives for cancer treatment | Signal Transduction and Targeted Therapy
Infectious Causes of Malignancy - Charles M. Callahan, Albert L. Vincent, John N. Greene, Ramon L. Sandin, 1999
Clinics and Practice | Free Full-Text | The Role of Immune Checkpoint Inhibitors in Cancer Therapy
Current Oncology | Free Full-Text | Immunotherapy in Extensive-Stage Small Cell Lung Cancer
Frontiers | Clinical course and management of insidious adrenal crisis manifested initially as hyperpyrexia secondary to pembrolizumab: Case reports and literature review
Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: Systematic review and meta-analysis | PLOS ONE
Slide27.JPG
Frontiers | Immunotherapy Associated Neurotoxicity in Pediatric Oncology
Cancer vaccines on the move | Nature Reviews Clinical Oncology
Cancers | Free Full-Text | Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice
Frontiers | Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
Frontiers | Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies - Huck - 2018 - Angewandte Chemie International Edition - Wiley Online Library
Current Oncology | Free Full-Text | Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art
Current Oncology | Free Full-Text | Immune Checkpoint Inhibitors in Cancer Therapy
Current Oncology | Free Full-Text | The Use of Breath Analysis in the Management of Lung Cancer: Is It Ready for Primetime?
Frontiers | Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients
Cancers | Free Full-Text | Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
Clinical impact of tumour biology in the management of gastroesophageal cancer | Nature Reviews Clinical Oncology
Biomedicines | Free Full-Text | Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors
